Gilead Sciences

China approves flu drug being touted as a potential coronavirus treatment amid a rush of clinical studies
Endpoints
Tue, 02/18/20 - 10:31 am
China
COVID-19
coronaviruses
fapilavir
Gilead Sciences
Blockbusters in waiting: drug launches to watch in 2020
Pharmaforum
Mon, 02/17/20 - 11:33 pm
drug launches
Biohaven
rimegepant
Novartis
ofatumumab
Celgene
ozanimod
Akebia Therapeutics
vadadustat
Biomarin
valrox
Gilead Sciences
filgotinib
Novo Nordisk
oral semaglutide
inclisiran
Immunomedics
sacituzumab govitecan
AstraZeneca
Enhertu
Bristol-Myers Squibb
liso-cel
Chinese firm copycats Gilead's remdesivir, the most promising drug against the new coronavirus
Fierce Pharma
Wed, 02/12/20 - 10:57 am
China
coronavirus
COVID-19
remdesivir
Gilead Sciences
patents
BrightGene
Is Gilead Sciences an Acquisition Target?
Motley Fool
Tue, 02/11/20 - 11:38 pm
Gilead Sciences
M&A
Gilead closes in on second CAR-T approval in US
Pharmaforum
Tue, 02/11/20 - 10:30 am
FDA
Gilead Sciences
Kite Pharma
mantle cell lymphoma
CAR-T
FDA Grants Priority Review For Kite's KTE-X19 BLA
NASDAQ
Mon, 02/10/20 - 10:27 am
Gilead Sciences
Kite Pharma
KTE-X19
priority review
FDA
mantle cell lymphoma
Gilead Sciences: Still on the Path to Recovery
Motley Fool
Sun, 02/9/20 - 04:17 pm
Gilead Sciences
earnings
Gilead loses first PrEP patent challenge but vows to defend against HHS lawsuit
Fierce Pharma
Fri, 02/7/20 - 10:38 am
Gilead Sciences
HHS
HIV
patents
PrEP
Truvada
Gilead CEO O'Day feels 'sense of urgency' on dealmaking as Kite writedowns add up
Fierce Pharma
Wed, 02/5/20 - 10:13 pm
Gilead Sciences
Kite Pharma
Daniel O'Day
Pharma CEOs
Wuhan Institute asks for patent on Gilead’s potential coronavirus drug
Pharmaforum
Wed, 02/5/20 - 10:23 am
China
Gilead Sciences
patents
Wuhan Coronavirus
remdesivir
Gilead Announces Q4 Financial Results, Misses EPS Target
Motley Fool
Tue, 02/4/20 - 11:26 pm
Gilead Sciences
earnings
Here's Why Inovio Pharmaceuticals and Vir Biotechnology Shares Have Fallen Today
Motley Fool
Tue, 02/4/20 - 12:00 am
Inovio
Vir Biotechnology
Gilead Sciences
Wuhan Coronavirus
China
remdesivir
Gilead climbs as coronavirus drug shows efficacy, starts trial
Fierce Biotech
Mon, 02/3/20 - 11:00 am
Gilead Sciences
remdesivir
China
Wuhan Coronavirus
3 Big Drugmakers Are Taking On the Coronavirus
Motley Fool
Mon, 02/3/20 - 10:32 am
Gilead Sciences
Moderna Therapeutics
Roche
Wuhan Coronavirus
China
J&J jumping in on coronavirus vax work as disease continues its spread
Fierce Biotech
Mon, 01/27/20 - 10:48 am
JNJ
vaccines
Wuhan Coronavirus
Gilead Sciences
Moderna Therapeutics
5 Biotechs to Watch With the Coronavirus Scare
Motley Fool
Sun, 01/26/20 - 01:44 pm
Wuhan Coronavirus
Biocryst
Gilead Sciences
Inovio
Moderna Therapeutics
Novavax
Hey Sanofi, you need to freshen up your pipeline, perhaps with M&A: report
Fierce Pharma
Fri, 01/24/20 - 11:02 am
Sanofi
M&A
Gilead Sciences
Gilead Considering Ebola Drug as Potential Coronavirus Treatment
Motley Fool
Thu, 01/23/20 - 11:56 pm
Gilead Sciences
Wuhan Coronavirus
remdesivir
#JPM20: After Year of NASH collapses, all eyes on two biotechs
Endpoints
Thu, 01/16/20 - 10:14 am
NASH
JPMHC 20
Genfit
Gilead Sciences
JPM Monday roundup: No deals, but drug-pricing startup causes the biggest noise
Fierce Biotech
Tue, 01/14/20 - 10:19 am
JPMHC 2020
M&A
Gilead Sciences
Bristol-Myers Squibb

Pages